Species : |
Human |
Source : |
P.pastoris |
Tag : |
Non |
Description : |
CK-MB Type II possesses the naturally occurring carboxy-terminal amino acid lysine. This occurs during a myocardial infarct (MI or heart attack) when CK-MB Type II is released from damaged heart muscle, and the C-terminal lysine is cleaved in the blood stream, thus creating CK-MB Type I. This difference can be exploited in diagnosis of an MI. |
Physical Appearance : |
Sterile Filtered colourless liquid formulation. |
Purity : |
Greater than 95.0% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE. |
Formulation : |
Each mg of protein (15.8mg/ml) contains 20mM Tris-HCl, pH-6.8, 1mM EDTA and 1mM DTT. |
Biological Activity : |
The biological activity measured by the enzymatic activity of Creatine phosphokinase procedure No.45-UV, 1IU-1 µmole creatine phosphate was 892 IU/mg at 37 degrees celsius. |
Storage : |
CKMBITII although stable at 15℃ for 7 days, should be stored desiccated below -18℃. Please prevent freeze-thaw cycles. |